Original Data

Diabetic Cardiomyopathy in OVE26 Mice Shows Mitochondrial ROS Production and Divergence Between In Vivo and In Vitro Contractility

Ye Song¹, Yibo Du¹, Sumanth D. Prabhu², Paul N. Epstein¹

Keywords: type 1 diabetes, cardiomyopathy, contractility, cardiomyocytes, echocardiography, mitochondria, reactive oxygen species

Abstract

Many diabetic patients suffer from a cardiomyopathy that cannot be explained solely by poor coronary perfusion. This cardiomyopathy may be due to either organ-based damage like fibrosis, or to direct damage to cardiomyocytes. Mitochondrial-derived reactive oxygen species (ROS) have been proposed to contribute to this cardiomyopathy. To address these questions, we used the OVE26 mouse model of severe type 1 diabetes to measure contractility in isolated cardiomyocytes by edge detection and in vivo with echocardiography. We also assessed the source of ROS generation using both a general and a mitochondrial specific indicator. When contractility was assayed in freshly isolated myocytes, contraction was much stronger in control myocytes. However, contractility of normal myocytes became weaker during 24 hours of in vitro culture. In contrast, contractility of diabetic OVE26 myocytes remains stable during culture. Echocardiography revealed normal or hyperdynamic function in OVE26 hearts under basal conditions but with a sharply reduced response to isoproterenol, a β-adrenergic agonist. For ROS generation, we found that ROS production in diabetic myocytes was elevated after exposure to either high glucose or angiotensin II (AngII). Superoxide detection with the mitochondrial sensor MitoSOX Red confirmed that mitochondria are a major source of ROS generation in diabetic myocytes. These results show that contractile deficits in OVE26 diabetic hearts are due primarily to cardiomyocyte impairment and that ROS from mitochondria are a cause of that impairment.

Fulltext: HTML , PDF (399KB)

This article has been cited by other articles:

	Structural remodeling of vagal afferent innervation of aortic arch and nucleus ambiguus (NA) projections to cardiac ganglia in a transgenic mouse model of type 1 diabetes (OVE26) Li L, Huang C, Ai J, Yan B, Gu H, Ma Z, Li AY, Xinyan S, Harden SW, Hatcher JT, Wurster RD, Cheng ZJ J Comp Neurol 2010. 518(14):2771-2793
	The sites and topology of mitochondrial superoxide production Brand MD Exp Gerontol 2010. 45(7-8):466-472
	Alcohol dehydrogenase accentuates ethanol-induced myocardial dysfunction and mitochondrial damage in mice: role of mitochondrial death pathway Guo R, Ren J PLoS One 2010. 5(1):e8757
	Impaired baroreflex control of renal sympathetic nerve activity in type 1 diabetic mice (OVE26) Gu H, Zhang ZH, Epstein PN, Li L, Harden SW, Wurster RD, Cheng ZJ Neuroscience 2009. 161(1):78-85
	Metallothionein abrogates GTP cyclohydrolase I inhibition-induced cardiac contractile and morphological defects: role of mitochondrial biogenesis Ceylan-Isik AF, Guo KK, Carlson EC, Privratsky JR, Liao SJ, Cai L, Chen AF, Ren J Hypertension 2009. 53(6):1023-1031
	Nrf2 is critical in defense against high glucose-induced oxidative damage in cardiomyocytes He X, Kan H, Cai L, Ma Q J Mol Cell Cardiol 2009. 46(1):47-58
	The complexities of diabetic cardiomyopathy: lessons from patients and animal models Harmancey R, Taegtmeyer H Curr Diab Rep 2008. 8(3):243-248